STOCKHOLM, SE / ACCESS Newswire / January 29, 2025 / Vicore Pharma Holding (STO:VICO)Stockholm, January 29, 2025 - Vicore Pharma Holding AB (STO: VICO), unlocking the potential of a novel class of ...
Several ASX-listed companies are making significant strides in their phase III clinical trials, the critical final stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback